| Insulin-like growth factor-I–dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells TR Graham, HE Zhau, VA Odero-Marah, AO Osunkoya, KS Kimbro, ... Cancer research 68 (7), 2479-2488, 2008 | 475 | 2008 |
| A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer DJ Cheon, Y Tong, MS Sim, J Dering, D Berel, X Cui, J Lester, JA Beach, ... Clinical cancer research 20 (3), 711-723, 2014 | 429 | 2014 |
| BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization KH Ventii, NS Devi, KL Friedrich, TA Chernova, M Tighiouart, ... Cancer research 68 (17), 6953-6962, 2008 | 415 | 2008 |
| Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases AT Deyrup, M Tighiouart, AG Montag, SW Weiss The American journal of surgical pathology 32 (6), 924-927, 2008 | 346 | 2008 |
| Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation JT Thaiparambil, L Bender, T Ganesh, E Kline, P Patel, Y Liu, ... International journal of cancer 129 (11), 2744-2755, 2011 | 316 | 2011 |
| Metastatic lymph node burden and survival in oral cavity cancer AS Ho, S Kim, M Tighiouart, C Gudino, A Mita, KS Scher, A Laury, ... Journal of Clinical Oncology 35 (31), 3601-3609, 2017 | 276 | 2017 |
| Translation of innovative designs into phase I trials A Rogatko, D Schoeneck, W Jonas, M Tighiouart, FR Khuri, A Porter Journal of Clinical Oncology 25 (31), 4982-4986, 2007 | 273 | 2007 |
| HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors X Wang, J Li, Y Wang, KJ Cho, G Kim, A Gjyrezi, L Koenig, ... ACS nano 3 (10), 3165-3174, 2009 | 208 | 2009 |
| Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD B Watkins, M Qayed, C McCracken, B Bratrude, K Betz, Y Suessmuth, ... Journal of clinical oncology 39 (17), 1865-1877, 2021 | 186 | 2021 |
| Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma NK Saxena, PP Fu, A Nagalingam, J Wang, J Handy, C Cohen, ... Gastroenterology 139 (5), 1762-1773. e5, 2010 | 179 | 2010 |
| Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma N McLean, M Tighiouart, S Muller Oral oncology 44 (11), 1039-1046, 2008 | 174 | 2008 |
| A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model X Wang, J Li, Y Wang, L Koenig, A Gjyrezi, P Giannakakou, EH Shin, ... ACS nano 5 (8), 6184-6194, 2011 | 157 | 2011 |
| Enhanced anti-tumor activity by the combination of the natural compounds (−)-epigallocatechin-3-gallate and luteolin: potential role of p53 ARMR Amin, D Wang, H Zhang, S Peng, HJC Shin, JC Brandes, ... Journal of Biological Chemistry 285 (45), 34557-34565, 2010 | 138 | 2010 |
| Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma MP Korah, N Esiashvili, CM Mazewski, RJ Hudgins, M Tighiouart, ... International Journal of Radiation Oncology* Biology* Physics 77 (1), 106-112, 2010 | 138 | 2010 |
| Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitor X Zhang, H Zhang, M Tighiouart, JE Lee, HJ Shin, FR Khuri, CS Yang, ... International journal of cancer 123 (5), 1005-1014, 2008 | 138 | 2008 |
| Treatment at high‐volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer JM David, AS Ho, M Luu, EJ Yoshida, S Kim, AC Mita, KS Scher, SL Shiao, ... Cancer 123 (20), 3933-3942, 2017 | 136 | 2017 |
| Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases AT Deyrup, JK McKenney, M Tighiouart, AL Folpe, SW Weiss The American journal of surgical pathology 32 (1), 72-77, 2008 | 126 | 2008 |
| A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose-and schedule-finding study S Lonial, J Kaufman, M Tighiouart, A Nooka, AA Langston, LT Heffner, ... Clinical Cancer Research 16 (20), 5079-5086, 2010 | 122 | 2010 |
| Targeted cancer gene therapy using a hypoxia inducible factor–dependent oncolytic adenovirus armed with interleukin-4 DE Post, EM Sandberg, MM Kyle, NS Devi, DJ Brat, Z Xu, M Tighiouart, ... Cancer research 67 (14), 6872-6881, 2007 | 122 | 2007 |
| Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control M Tighiouart, A Rogatko, JS Babb Statistics in medicine 24 (14), 2183-2196, 2005 | 122 | 2005 |
